Scholl

COLLEGE FOR CREATIVE STUDIES FASHION DESIGN PROGRAM PRESENTS FOURTH ANNUAL RUNWAY FASHION SHOW

Retrieved on: 
星期二, 五月 7, 2024
Education, Simion, American frontier, Full Speed, Aircraft, Nature, Woman, World War II, Freezing, Scholl, Accident, Love, Empowerment, Collection, Flower, Photography, Veronica, Water, Life, W (magazine), Show, Curriculum, Female, CCS, History, Patent, College, Fashion design, Femininity, Workforce, Fruit, Temperature, Student, Human, Sleep, Rodriguez, Running

Detroit, MI, May 07, 2024 (GLOBE NEWSWIRE) -- On Saturday, May 4, 2024, The College for Creative Studies (CCS) presented its fourth iteration of The Show, a runway show featuring collections from 23 students enrolled in the Fashion Design program.

Key Points: 
  • Detroit, MI, May 07, 2024 (GLOBE NEWSWIRE) -- On Saturday, May 4, 2024, The College for Creative Studies (CCS) presented its fourth iteration of The Show, a runway show featuring collections from 23 students enrolled in the Fashion Design program.
  • “I am continuously inspired by how students each year bring their design concepts to fruition,” said Aki Choklat, Linda Dresner Endowed Chair in Fashion Design.
  • The College for Creative Studies Fashion Accessories Design program, heralded as the largest and most equipped fashion accessory design department in the United States, was established in 2015 under the leadership of renowned footwear designer Aki Choklat.
  • The program, up until 2022, has focused on fashion accessories design such as footwear, handbags, and small leather goods.

Montway Auto Transport Launches Preferred Carrier Network Program

Retrieved on: 
星期二, 五月 7, 2024
Scholl, Telephone

CHICAGO, May 7, 2024 /PRNewswire/ -- Montway Auto Transport, one of the nation's leading third-party logistics brokerages and a pioneer in the car shipping industry, proudly announced the launch of its Preferred Carrier Network program—an initiative designed to attract and reward high-caliber car haulers. This unique program offers unmatched benefits to carriers, including access to technology that can add efficiency to their operation and grow their business.

Key Points: 
  • CHICAGO, May 7, 2024 /PRNewswire/ -- Montway Auto Transport , one of the nation's leading third-party logistics brokerages and a pioneer in the car shipping industry, proudly announced the launch of its Preferred Carrier Network program—an initiative designed to attract and reward high-caliber car haulers.
  • "There are few jobs more demanding than a truck driver," said Mark Scholl, Executive Vice President of Operations and Retail Sales at Montway Auto Transport.
  • Key attractions of Montway's Preferred Carrier Network entail:
    These advantages are underpinned by advanced technology, increased new business and integrations with leading remarketing platforms such as EDGE Pipeline from Auction EDGE.
  • This trailblazing program is part of Montway's commitment to revolutionizing the auto transport industry and establishing new benchmarks for carrier support and success.

Dr. William M. Scholl College of Podiatric Medicine at Rosalind Franklin University Announces Historic $1 Million Matching-Fund Scholarship Challenge

Retrieved on: 
星期三, 十二月 13, 2023
Gait, Research, Conditional sentence, Student, Patient, RFU, Master of Science, DPM, Podiatry, Lead, Education, Pharmaceutical industry, Nursing, Scholl

NORTH CHICAGO, Ill., Dec. 13, 2023 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science (RFU) announces a historic $1 million matching gift commitment for the Dr. William M. Scholl College of Podiatric Medicine .

Key Points: 
  • NORTH CHICAGO, Ill., Dec. 13, 2023 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science (RFU) announces a historic $1 million matching gift commitment for the Dr. William M. Scholl College of Podiatric Medicine .
  • Historic $1 million matching gift commitment for the Dr. William M. Scholl College of Podiatric Medicine.
  • The extraordinary $1 million Scholl Matching Gift Challenge comes from an anonymous Scholl College alum and their spouse, generously committing to match all gifts toward the college dollar-for-dollar.
  • Matching funds will grow an endowed scholarship to provide four-year, need-based scholarships for Scholl College students in perpetuity.

Rob Scholl Named President & CEO of Textron Specialized Vehicles Inc.; Kriya Shortt Named President & CEO of Textron eAviation

Retrieved on: 
星期一, 八月 21, 2023
Insurance, Finance, Other Energy, Chemicals, Plastics, Automotive Manufacturing, Aerospace, Professional Services, Manufacturing, Energy, McCauley Propeller Systems, Business development, Inc., Part program, Marketing, Part, TSV, Acosta Sales & Marketing, Aviation, Business, Multimedia, United Nations Convention on Contracts for the International Sale of Goods, Textron Aviation, Scholl, Customer service, Corporation, Donnelly (surname), Flight operations quality assurance, NYSE, Management, Textron, Kriyā

Textron Inc. (NYSE: TXT) today announced that Rob Scholl, president & CEO of Textron eAviation, has been named president & CEO of Textron Specialized Vehicles Inc. and Kriya Shortt, senior vice president, Global Parts & Distribution, at Textron Aviation, has been named president & CEO of Textron eAviation, succeeding Scholl.

Key Points: 
  • Textron Inc. (NYSE: TXT) today announced that Rob Scholl, president & CEO of Textron eAviation, has been named president & CEO of Textron Specialized Vehicles Inc. and Kriya Shortt, senior vice president, Global Parts & Distribution, at Textron Aviation, has been named president & CEO of Textron eAviation, succeeding Scholl.
  • With 17 years of experience at Textron, Scholl has served in leadership roles across the company, including senior vice president, Global Sales & Flight Operations, vice president, Parts & Programs and vice president, Marketing at Textron Aviation.
  • Most recently, she served as senior vice president, Global Parts & Distribution, and president of Able Aerospace and McCauley Propeller Systems.
  • She has also served as senior vice president, Customer Service, senior vice president, Sales, and vice president, International Sales.

Alight Reports Second Quarter Results

Retrieved on: 
星期二, 八月 1, 2023
Technology, Human Resources, Consulting, Professional Services, Business, Software, Networks, Data Analytics, Data Management, Artificial Intelligence, Professional services, Weis Markets, Katie, GAAP, Central Time, Movement, As a service, Interest, Siemens Healthineers, EBITDA, Scholl, Acquisition, TCV, Growth, EPS, Business process, NYSE, Health care, Video game, Bank, Management, Maersk

Alight, Inc. (NYSE: ALIT), a leading cloud-based provider of integrated digital human capital and business solutions, today reported results for the second quarter ended June 30, 2023.

Key Points: 
  • Alight, Inc. (NYSE: ALIT), a leading cloud-based provider of integrated digital human capital and business solutions, today reported results for the second quarter ended June 30, 2023.
  • “Alight delivered strong financial performance in the second quarter with double digit growth across revenue, profitability and operating cash flow,” said Chief Executive Officer Stephan Scholl.
  • For the same reasons, we are unable to address the probable significance of the unavailable information, which could be material to future results.
  • In addition to highlighting its second quarter results, the Company is also announcing that Katie Rooney, Chief Financial Officer of Alight will also be assuming the role of Chief Operating Officer, effective immediately.

Global Strat View: PM Modi's Visit an Opportunity to Advance India US Strategic Partnership

Retrieved on: 
星期五, 六月 16, 2023
Patent, Pentagon, Cyber-security regulation, Partnership, Defense, Friends, GE, IP, FMR, Policy, GSV, Office of the Secretary of Defense, Narendra Modi, Computer security, Vaccine, Scholl

WASHINGTON, June 16, 2023 /PRNewswire/ -- Global Strat View (GSV) hosted an event on the US-India Strategic Partnership, focusing on trade, security, and defense cooperation.

Key Points: 
  • WASHINGTON, June 16, 2023 /PRNewswire/ -- Global Strat View (GSV) hosted an event on the US-India Strategic Partnership, focusing on trade, security, and defense cooperation.
  • Col. Mills emphasized the importance of strengthening US-India Relations to deter China's global malign influence.
  • Scholl expressed that the private sectors of India and the US are figuring out a closer form of economic partnership with the steady increase of global investments in the Indian market.
  • Notwithstanding India's long-standing relations with Russia, Scholl noted that the upcoming visit presents a rare opportunity for the US to partner with India because "India is looking for friends, and frankly, so are we."

Loyal Appoints Blake Scholl to its Board of Directors

Retrieved on: 
星期三, 二月 15, 2023
Biotechnology, Technology, Health, Pharmaceutical, Air, Pets, Transport, Other Technology, Consumer, Hardware, Veterinary, Black box group, Josie, Groupon, Scholl, Ageing, Friends, History, Amazon, Boom, FDA, Multimedia, XB-1, Learning, Boom Technology, Dog, First Round Capital, Longevity, Pharmaceutical industry, Loyal, Overture

Loyal , a biotech company developing the world’s first drugs intended to extend the healthy lifespan of dogs, announced today that Blake Scholl has joined as an Independent Director.

Key Points: 
  • Loyal , a biotech company developing the world’s first drugs intended to extend the healthy lifespan of dogs, announced today that Blake Scholl has joined as an Independent Director.
  • View the full release here: https://www.businesswire.com/news/home/20230215005837/en/
    Loyal appoints Blake Scholl to Board of Directors (Photo: Business Wire)
    Blake Scholl is the Founder and CEO of Boom Supersonic , the company building the world’s fastest airliner.
  • Prior to founding Boom in 2014, Blake held leadership roles at Amazon and Groupon and co-founded mobile technology startup Kima Labs.
  • Blake joins existing Board of Directors Laura Deming of The Longevity Fund and Celine Halioua, and Board Observers Josh Kopelman of First Round Capital and Greg Rosen of Box Group.

Dr. Scholl's Teams Up with Sportscaster Erin Andrews on her Road to the Big Game

Retrieved on: 
星期五, 一月 27, 2023
Foot, Himalaya Wellness Company, Massage, SVP, Fatigue, Shock, Health, Partnership, Countless Hours Making Waves, Scholl, Arm, Heel, Joint, Marketing, Sports equipment, Shoemaking

PARSIPPANY, N.J., Jan. 27, 2023 /PRNewswire/ -- Dr. Scholl's®, the most trusted brand in foot care, announced its partnership today with sports journalist & Entrepreneur Erin Andrews in preparation for her journey to the big game. As Andrews reflects on this past football season and prepares to take the year's brightest sideline spotlight, she is sharing her secrets to getting through it all comfortably on her feet.

Key Points: 
  • PARSIPPANY, N.J., Jan. 27, 2023 /PRNewswire/ -- Dr. Scholl's®, the most trusted brand in foot care, announced its partnership today with sports journalist & Entrepreneur Erin Andrews in preparation for her journey to the big game.
  • "The countless hours spent on my feet throughout the season can take a toll on my body, leaving me – and my feet – exhausted."
  • Scholl's®."
  • Andrews stashes Dr. Scholl's® Severe Cracked Heel Balm easy-to-use stick applicator in her carry-on while traveling to hydrate, soothe, soften and protect her feet on the go.

Combined impact of flu and COVID-19 expected to continue to plague U.S. businesses this winter

Retrieved on: 
星期四, 十一月 3, 2022
RSV, Incidence, Reckitt, Vaccination, COVID, Infection, Risk, Virus, Prevalence, COVID-19, Air Wick, Taiwan, Veet, Private sector, Hand, CDC, Epidemiology, Ibuprofen brand names, Hygiene, Air Canada, Clearasil, Intelligence, Health, Rhinovirus, BlueDot, City, Partnership, Degenerative disease, Weather, Air travel, Multimedia, Respiratory syncytial virus, Influenza, Enfamil, Research and development, EPA, Vaccine, Animal, Pharmaceutical industry, Tissue paper, Taiwan Centers for Disease Control, Calgon, Durex, Scholl, Vanish, Dettol, Lysol, Research, Woolite

PARSIPPANY, N.J., Nov. 3, 2022 /PRNewswire/ -- Analysis by Reckitt's Lysol Pro Solutions, a science-led business to business offering, in partnership with BlueDot Inc., the leading artificial and human intelligence organization for detecting, assessing, and responding to global infectious diseases, indicates a potentially severe season of respiratory viruses this winter in the U.S.

Key Points: 
  • Continued increase in air travel following the pandemic is likely to increase the spread of both cold and flu as well as COVID-19.
  • It's important that everyone - both businesses and citizens - play a role in helping to combat the spread of respiratory diseases.
  • "U.S. businesses are likely to be hit hard by the impact of a severe respiratory virus season, impacting worker productivity.
  • It is reasonable to expect that the timing of flu peaks throughout the rest of this season will be similarly unpredictable.

Neurotech Pharmaceuticals, Inc. Announces Positive Phase 3 Topline Results for NT-501 Implant in Macular Telangiectasia Type 2

Retrieved on: 
星期三, 十一月 2, 2022
Health, Clinical Trials, Research, Science, Pharmaceutical, Optical, Biotechnology, Medication, ECT, Epithelium, Time, Glaucoma, Macular telangiectasia, Eye, CNTF, Cell, Safety, Technology, Compliance, Review, Scholl, FDA, Colonial architecture, Patient, Prevalence, Severe cognitive impairment, Neurodegeneration, Pharmaceutical industry, Publishing, Medical device, S.S, Chewing, Neurotechnology

We are extremely pleased to see these positive topline data for MacTel since there has been no pharmacological treatment to date, said Richard Small, Chief Executive Officer of Neurotech.

Key Points: 
  • We are extremely pleased to see these positive topline data for MacTel since there has been no pharmacological treatment to date, said Richard Small, Chief Executive Officer of Neurotech.
  • After a long period of intensive research, development, and clinical trials, we are extremely gratified with our Phase 3 results, stated Thomas Aaberg Jr., M.D., Chief Medical Officer of Neurotech.
  • Neurotech is currently studying in the clinic ECT candidates to treat Macular telangiectasia type 2 and glaucoma.
  • Charbel Issa P, Gillies MC, Chew EY, Heeren TFC, Bird AC, Peto T, Holz FG, Scholl HPN (2013) Macular Telangiectasia Type 2.